Board of Scientific and Medical Advisors

The DxNA Board of Science Advisors provides its expertise on an ongoing basis. The Board is regularly informed by DxNA on scientific, medical and technical activities and contributes objective feedback and ideas to better final results, accelerate the development process and reduce time-to-revenue. Its functions include: (1) providing experience and expertise in areas of development not internally available, (2) acting as ambassadors for DxNA and its technology, (3) evaluating new technologies or intellectual property, (4) suggesting further projects leading towards direct clinical application, and (5) providing guidance regarding regulatory issues and activities.

The Board has the diversity needed to properly address matters from both domestic and worldwide perspectives.

Nirbhay Kumar, Ph.D.
Professor, Department of Molecular Microbiology and Epidemiology
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University

Paul Blumenthal, M.D., M.P.H.
Professor, Division of Gynecologic Specialties
Director of the Center for Contraceptive Health and Research at Stanford (CCHR)
Director of Ambulatory Care in the Division of Gynecologic Specialties
Department of Obstetrics and Gynecology
Stanford Univeristy School of Medicine

Anthony R. Torres, M.D.
Director, Biomedical Laboratory at the Center for Persons with Disabilities (CPD)
Utah State University
 
Richard Webby, Ph.D.
Department of Virology & Molecular Biology 
St. Jude Children's Research Hospital
University of Tennessee